Liven Pharma Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-762.21	-584.46	41.74	-12.33	-14.29	-14.63
Depreciation & Amortization	34.23	27.17	24.87	13.1	14.56	16.08
Other Amortization	328.34	328.27	0.69	-	-	-
Provision & Write-off of Bad Debts	117.55	116.87	-	-	-	-
Other Operating Activities	153.31	92.58	1.15	-2.9	-3.22	-3.55
Change in Accounts Receivable	-23.15	-21.52	-42.29	-	-	-
Change in Inventory	13.9	0.46	-11.82	-	-	-
Change in Accounts Payable	49.78	39.43	0.21	-	-0.07	-4.16
Change in Other Net Operating Assets	-4.25	-0.52	-0.75	-0.14	0.76	-0.52
Operating Cash Flow	-7.08	-1.72	13.8	-2.27	-2.26	-6.79
Capital Expenditures	-23.06	-22.84	-	-	-	-
Sale (Purchase) of Intangibles	-10	-10	-	-	-	-
Investing Cash Flow	-242.48	-32.84	-	-	-	-
Short-Term Debt Issued	-	168.72	11.34	2.27	2.24	6.79
Long-Term Debt Issued	-	6.68	1.36	-	-	-
Total Debt Issued	201.7	175.4	12.7	2.27	2.24	6.79
Short-Term Debt Repaid	-	-156.14	-	-	-	-
Long-Term Debt Repaid	-	-1.8	-3.54	-	-	-
Total Debt Repaid	23.59	-157.94	-3.54	-	-	-
Net Debt Issued (Repaid)	225.3	17.46	9.16	2.27	2.24	6.79
Financing Cash Flow	225.3	17.46	9.16	2.27	2.24	6.79
Miscellaneous Cash Flow Adjustments	-24.92	0.03	-	-	-	-
Net Cash Flow	-49.18	-17.07	22.96	0	-0.02	-0.01
Free Cash Flow	-30.13	-24.56	13.8	-2.27	-2.26	-6.79
Free Cash Flow Margin	-63.87%	-19.30%	5.63%	-	-	-
Free Cash Flow Per Share	-0.34	-0.35	345.08	-0.19	-0.19	-0.56
Cash Interest Paid	1.06	0.47	0.1	-	-	-
Levered Free Cash Flow	163.81	151.56	-163.82	3.45	4.31	0.03
Unlevered Free Cash Flow	164.66	152.02	-163.81	3.45	4.31	0.03
Change in Working Capital	36.27	17.84	-54.65	-0.14	0.7	-4.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.